The purpose of this study is to investigate the treatment of pancreatic adenocarcinoma using proton radiation. This study investigates how this treatment may affect the condition.
This study evaluates the effectiveness of combining proton radiation with oral chemotherapy. It will look at how this combination may improve treatment outcomes.
- Who can participate: Adults with pancreatic adenocarcinoma that is unresectable, borderline resectable, or medically inoperable can participate. Participants must have a drainage tube for biliary obstruction and meet certain lab criteria.
- Study details: Participants will receive proton radiation over 6 weeks, with oral chemotherapy on radiation days. If surgery becomes an option, it will occur at least 8 weeks after treatment.
How understandable was the trial content above?
Hard to understand
Easy to understand